Nuclein
Austin
About Nuclein
Nuclein is a biotechnology company that develops the Hand-Held Polymerase Chain Reaction test device for infectious diseases. The test device is a disposable, all-in-one, self-testing device for infectious disease diagnosis that does not require any technical expertise and provides battery-powered, sample-to-answer results in under one hour, without the need to mail in a sample.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $43.7M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Oct 2025)
- Website: nuclein.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nuclein-42833 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.